[Cardiovascular risk factor reduction. Cholesterol absorption inhibitors: a new action principle].
Schunack
Walter
W
Freie Universität Berlin Institut für Pharmazie Königin-Luise-Strasse 2+4 14195 Berlin. sieker@schunet.pharmazie.fu-berlin.de
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002791:Cholesterol, Dietary / Q000493:pharmacokinetics*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000235:genetics; D007408:Intestinal Absorption / Q000187:drug effects*; D012307:Risk Factors
D000924:Anticholesteremic Agents; D001384:Azetidines; D002791:Cholesterol, Dietary; D000069438:Ezetimibe